Mario Corso Joins Leerink Swann & Company as Vice President-Senior Analyst, Pharmaceuticals

Apr 27, 2001, 01:00 ET from Leerink Swann & Company

    BOSTON, April 27 /PRNewswire/ -- Mario Corso has joined Leerink Swann &
 Company as Vice President-Senior Analyst, Pharmaceuticals. His focus is on
 large cap, multinational pharmaceutical companies, and he has been following
 the sector since 1996. Mr. Corso joins us from ABN AMRO where he had been
 covering large cap pharmaceutical companies for the past three years.
 Additional previous affiliations include Rodman and Renshaw, Copley
 Pharmaceuticals and Scudder Investments. He has an MBA from Northeastern
 University and a Bachelor of Arts in Economics from the University of
 Connecticut.
 
     About Leerink Swann & Company
     Leerink Swann & Company, recently ranked 30th on the Inc. 500 list of the
 country's fastest growing companies, is a full-service investment banking firm
 that provides institutional sales, healthcare equity research, corporate
 finance, asset management services for high net worth clients, and
 institutional sales. Through its subsidiary MEDACorp, Leerink Swann & Company
 provides biomedical-consulting services to Life Science companies and to the
 institutional investment community. MEDACorp is comprised of more than 2,000
 consultants who are practicing physicians, surgeons, and biomedical
 professionals representing 48 clinical care specialties and 22 basic science
 disciplines.
     For information on Leerink Swann & Company's coverage of large cap
 pharmaceuticals, please contact Mr. Corso at (617) 918-4536.  For more
 information on this press release, contact Katie Gilbert (617) 918-4528.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X04183622
 
 

SOURCE Leerink Swann & Company
    BOSTON, April 27 /PRNewswire/ -- Mario Corso has joined Leerink Swann &
 Company as Vice President-Senior Analyst, Pharmaceuticals. His focus is on
 large cap, multinational pharmaceutical companies, and he has been following
 the sector since 1996. Mr. Corso joins us from ABN AMRO where he had been
 covering large cap pharmaceutical companies for the past three years.
 Additional previous affiliations include Rodman and Renshaw, Copley
 Pharmaceuticals and Scudder Investments. He has an MBA from Northeastern
 University and a Bachelor of Arts in Economics from the University of
 Connecticut.
 
     About Leerink Swann & Company
     Leerink Swann & Company, recently ranked 30th on the Inc. 500 list of the
 country's fastest growing companies, is a full-service investment banking firm
 that provides institutional sales, healthcare equity research, corporate
 finance, asset management services for high net worth clients, and
 institutional sales. Through its subsidiary MEDACorp, Leerink Swann & Company
 provides biomedical-consulting services to Life Science companies and to the
 institutional investment community. MEDACorp is comprised of more than 2,000
 consultants who are practicing physicians, surgeons, and biomedical
 professionals representing 48 clinical care specialties and 22 basic science
 disciplines.
     For information on Leerink Swann & Company's coverage of large cap
 pharmaceuticals, please contact Mr. Corso at (617) 918-4536.  For more
 information on this press release, contact Katie Gilbert (617) 918-4528.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X04183622
 
 SOURCE  Leerink Swann & Company